Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Device Automates Collection of Extracellular Vesicles from Biological Fluids

By LabMedica International staff writers
Posted on 15 Mar 2017
A team of Korean cancer researchers has developed an automated system for isolating extracellular vesicles from biological fluids such as cell culture growth medium, urine, or blood.

Extracellular vesicles (EVs) are cell-derived nanoscale vacuoles that can transport nucleic acids and proteins from their cells of origin and show great potential as biomarkers for many diseases, including cancer. More...
Current methods of EV isolation and analysis require time-consuming complicated procedures, including ultracentrifugation, and demand large amounts of sample material.

To simplify the isolation and analysis of EVs, investigators at Ulsan National Institute of Science and Technology developed a rapid, label-free, and highly sensitive method based on a lab-on-a-disc device integrated with two nanofilters. This "Exodisc" device is composed of two independent filtration units (20 nanometers and 600 nanometers in size) within a disk-shaped chip. While being processed for 30 minutes in a tabletop-sized centrifugal microfluidic system, the sample is transferred through the two integrated nanofilters, which enriches EVs within the size range of 20 to 600 nanometers.

The investigators used a quantitative nanoparticle-tracking analysis technique to show that the Exodisc device enabled greater than 95% recovery of EVs from cell culture supernatant. Analysis of mRNA retrieved from EVs revealed that the Exodisc provided more than 100-fold higher concentration of mRNA as compared with the gold-standard ultracentrifugation method. In addition, an on-disc enzyme-linked immunosorbent assay (ELISA) using urinary EVs isolated from bladder cancer patients showed high levels of the marker proteins CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.

"Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes," said senior author Dr. Yoon-Kyoung Cho, professor of biomedical engineering at Ulsan National Institute of Science and Technology. "The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs. We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles. We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings."

The Exodisc device was described in detail in the January 9, 2017, online edition of the journal ACS Nano.


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.